chlorzoxazone has been researched along with Fra(X) Syndrome in 1 studies
Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The mechanisms underlying hyperacusis in FXS are still largely unknown and effective therapies are lacking." | 1.91 | Hyperacusis in the Adult ( Bouleau, Y; Dulon, D; Ferraguto, C; Peineau, T; Pietropaolo, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferraguto, C | 1 |
| Bouleau, Y | 1 |
| Peineau, T | 1 |
| Dulon, D | 1 |
| Pietropaolo, S | 1 |
1 other study available for chlorzoxazone and Fra(X) Syndrome
| Article | Year |
|---|---|
Hyperacusis in the Adult
Topics: Animals; Auditory Pathways; Chlorzoxazone; Disease Models, Animal; Fragile X Mental Retardation Prot | 2023 |